Jack Kaye, Director at KERYX BIOPHARMACEUTICALS INC (KERX), sold 20,000 shares at $5.00 ($100K) on 2010-12-06, disclosed to the SEC on 2010-12-08.
Open-market sale of $100k KERX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| QURE | SELL | 2026-06-12 | $54K | — | Filing → |
| QURE | SELL | 2026-06-05 | $79K | — | Filing → |
| QURE | SELL | 2026-01-12 | $174K | — | Filing → |